April 25, 2025- Thermo Fisher Scientific Inc. will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector. These additional investments to the company’s American manufacturing capacity support a resilient U.S. healthcare supply chain and will have a strong multiplier effect across the American economy.
The $2 billion investment over the next four years includes:
- Complemented by $500 million in R&D focused on high-impact innovation
- $1.5 billion in capital expenditures to enhance and expand U.S. manufacturing operations